$ETST, an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device R&D, is pleased to announce the company has signed a deal with Laboratories BNK Canada, Inc. (http://www.labobnk.com/), for clinical studies related to the MSN-2 Medical Device.